According to the American Academy of Ophthalmology (AAO), almost 4 million Americans have gone through cataract surgery every year. Moreover, the AAO estimates that the number of people in the U.S. who will develop cataracts will rise from 24.4 million to 50 million by 2050, which means there will be significantly more cataract procedures. Therefore, hospitals, ambulatory surgery centers (ASCs), and eye surgery facilities can benefit from the growing demand for cataract surgeries.
The most frequent type of cataract surgery is inpatient, but some procedures can also be outpatient, making such facilities critical to meet the expanding need for the service. Surgeries can often be completed on an outpatient basis, making them more accessible to patients and less costly to insurers. ASCs can help eye surgeons complete such procedures while providing a controlled environment for post-surgery recovery. Moreover, ASCs may report paying roughly 62% of the HOPD rates for the same procedures, according to an analysis of Medicare data conducted by ASCA and released in May 2026. The report also stated that eye surgery is among the most common types of surgery performed in ASCs. Thus, a less expensive alternative to traditional hospitals is a compelling choice for payers, physicians, and patients, but specific cases will dictate whether a procedure will be performed in an inpatient or outpatient setting.
Medicare reimbursement policies and regulations are also significant external factors that may affect the market. Specifically, CMS’s payment rules and policies for services rendered in ASCs and HOPDs create a financial basis for determining the viability of providing services in these settings. On November 21, 2025, CMS published its 2026 outpatient payment rule, which includes a 2.6 percent payment update for certified ASCs and HOPDs. According to ASCA, the final rule will increase Medicare reimbursement for CPT 66984 code (“Cataract removal with intraocular lens implantation, with intraoperative microscope”), a common procedure for treating cataracts, by 3.4 percent compared to 2025. The stability of reimbursements and their payment updates are two crucial factors for healthcare facilities, dictating their development plans and influencing the choice between HOPD and ASC. Nevertheless, reimbursement growth is not the sole determinant of the market’s development and healthcare providers’ choices, as an organization should consider multiple costs associated with care delivery, including personnel, equipment, and quality of care, among others, and analyze the competitive landscape.
Technological advances to eye surgery equipment are further shaping provider investment and service trends. Modern phacoemulsification devices, sophisticated intraocular lenses, enhanced surgical instruments, and digital planning solutions contribute to ophthalmologists’ ability to design procedures and address a variety of patient needs. In April 2025, the ZEISS Medical Technology announced that more than 2 million cataract procedures in the United States have been digitally planned using its VERACITY Surgery Planner, illustrating the adoption of digital solutions by the eye surgery sector. Similarly, in June 2025, Alcon launched its Unity cataract surgery platform at a U.S. clinic, representing another step in the industry’s commitment to investing into leading-edge surgical equipment. The developments in question are expected to increase productivity and differentiate providers within the setting of an ambulatory surgery center (ASC) or a hospital’s outpatient department. That said, the cost of embracing the progress may challenge some smaller facilities, while the selection of a specific technology will depend on the needs of a given site and the scope of its projected surgical volume.
U.S. Cataract Surgery Site-of-Care Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the U.S. cataract surgery site-of-care market report based on product, CPT code, payer, end use:Product Outlook (Revenue, USD Unit, 2021 - 2033)
- IOLs
- Surgical Systems & Visualization
- Instruments & Disposables
- OVDs
- Others
CPT Code Outlook (Revenue, USD Unit, 2021 - 2033)
- 66982 (complex cataract surgeries)
- 66984 (routine cataract surgeries)
- 66991, 66989 (cataracts with MIGS)
- Others
Payer Outlook (Revenue, USD Unit, 2021 - 2033)
- Medicare
- Medicaid
- Commercial Insurance
- Others (self pay, VA and etc)
End Use Outlook (Revenue, USD Unit, 2021 - 2033)
- Hospital Outpatient Departments (HOPDs)
- Ambulatory Surgery Centers (ASCs)
- Office-Based Surgery (OBS) & independent clinics
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Companies Mentioned
- SCA Health
- USPI (Tenet)
- EyeSouth Partners
- Unifeye Vision Partners
- Bascom Palmer Eye Institute (Univ. of Miami)
- Wills Eye Hospital
- Cole Eye Institute (Cleveland Clinic)
- Massachusetts Eye and Ear
- EyeCare Partners
- Eye Health America

